To what extent lack of progression through mini-puberty, and its potential purpose in priming the testes, underlies poor response to treatment with GnRH or gonadotropins in adolescence or adulthood in males with CHH is not known at present. The gene discussed is GNRH1; the disease is cartilage-hair hypoplasia.